Cargando…
Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage
Ranolazine received Food and Drug Administration (FDA) approval in 2006 for the treatment of chronic angina. Ranolazine has previously been linked to the development of statin-induced myopathy, because it also inhibits CYP3A4, which increases serum statin levels. In the absence of concomitant statin...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101463/ https://www.ncbi.nlm.nih.gov/pubmed/30131925 http://dx.doi.org/10.7759/cureus.2832 |
_version_ | 1783349024283164672 |
---|---|
author | Dein, Eric Manno, Rebecca Syed, Abrahim Douglas, Homeyra Geetha, Duvuru Timlin, Homa |
author_facet | Dein, Eric Manno, Rebecca Syed, Abrahim Douglas, Homeyra Geetha, Duvuru Timlin, Homa |
author_sort | Dein, Eric |
collection | PubMed |
description | Ranolazine received Food and Drug Administration (FDA) approval in 2006 for the treatment of chronic angina. Ranolazine has previously been linked to the development of statin-induced myopathy, because it also inhibits CYP3A4, which increases serum statin levels. In the absence of concomitant statin therapy, elevated creatinine kinase (CK) and myalgias on ranolazine monotherapy has never been reported. |
format | Online Article Text |
id | pubmed-6101463 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-61014632018-08-21 Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage Dein, Eric Manno, Rebecca Syed, Abrahim Douglas, Homeyra Geetha, Duvuru Timlin, Homa Cureus Internal Medicine Ranolazine received Food and Drug Administration (FDA) approval in 2006 for the treatment of chronic angina. Ranolazine has previously been linked to the development of statin-induced myopathy, because it also inhibits CYP3A4, which increases serum statin levels. In the absence of concomitant statin therapy, elevated creatinine kinase (CK) and myalgias on ranolazine monotherapy has never been reported. Cureus 2018-06-18 /pmc/articles/PMC6101463/ /pubmed/30131925 http://dx.doi.org/10.7759/cureus.2832 Text en Copyright © 2018, Dein et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Dein, Eric Manno, Rebecca Syed, Abrahim Douglas, Homeyra Geetha, Duvuru Timlin, Homa Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage |
title | Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage |
title_full | Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage |
title_fullStr | Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage |
title_full_unstemmed | Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage |
title_short | Ranolazine-induced Elevation of Creatinine Kinase in the Absence of Statin Usage |
title_sort | ranolazine-induced elevation of creatinine kinase in the absence of statin usage |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101463/ https://www.ncbi.nlm.nih.gov/pubmed/30131925 http://dx.doi.org/10.7759/cureus.2832 |
work_keys_str_mv | AT deineric ranolazineinducedelevationofcreatininekinaseintheabsenceofstatinusage AT mannorebecca ranolazineinducedelevationofcreatininekinaseintheabsenceofstatinusage AT syedabrahim ranolazineinducedelevationofcreatininekinaseintheabsenceofstatinusage AT douglashomeyra ranolazineinducedelevationofcreatininekinaseintheabsenceofstatinusage AT geethaduvuru ranolazineinducedelevationofcreatininekinaseintheabsenceofstatinusage AT timlinhoma ranolazineinducedelevationofcreatininekinaseintheabsenceofstatinusage |